{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:41:48Z","timestamp":1763142108649,"version":"3.37.3"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071414"],"award-info":[{"award-number":["82071414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00415-023-11876-y","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T15:02:05Z","timestamp":1689951725000},"page":"5251-5273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions"],"prefix":"10.1007","volume":"270","author":[{"given":"BaoLing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eng-King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-6540","authenticated-orcid":false,"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"Pt 4","key":"11876_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/brain\/117.4.835","volume":"117","author":"GK Wenning","year":"1994","unstructured":"Wenning GK, Ben Shlomo Y, Magalh\u00e3es M, Daniel SE, Quinn NP (1994) Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain J Neurol 117(Pt 4):835\u2013845. https:\/\/doi.org\/10.1093\/brain\/117.4.835","journal-title":"Brain J Neurol"},{"key":"11876_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/s1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, K\u00f6llensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264\u2013274. https:\/\/doi.org\/10.1016\/s1474-4422(12)70327-7","journal-title":"Lancet Neurol"},{"key":"11876_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/wnl.38.3.419","volume":"38","author":"R Kurlan","year":"1988","unstructured":"Kurlan R, Rothfield KP, Woodward WR, Nutt JG, Miller C, Lichter D, Shoulson I (1988) Erratic gastric emptying of levodopa may cause \u201crandom\u201d fluctuations of parkinsonian mobility. Neurology 38:419\u2013421. https:\/\/doi.org\/10.1212\/wnl.38.3.419","journal-title":"Neurology"},{"key":"11876_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","volume":"33","author":"JA Palma","year":"2018","unstructured":"Palma JA, Kaufmann H (2018) Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 33:372\u2013390. https:\/\/doi.org\/10.1002\/mds.27344","journal-title":"Mov Disord"},{"key":"11876_CR5","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1093\/brain\/awv303","volume":"138","author":"C Colosimo","year":"2015","unstructured":"Colosimo C, Berardelli A (2015) Autonomic failure and reduced survival in multiple system atrophy. Brain J Neurol 138:3466\u20133468. https:\/\/doi.org\/10.1093\/brain\/awv303","journal-title":"Brain J Neurol"},{"key":"11876_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.14336\/ad.2022.0514","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu H, Huang Z, Deng B, Chang Z, Yang X, Guo X, Yuan F, Yang Q, Wang L, Zou H, Li M, Zhu Z, Jin K, Wang Q (2023) QEEG signatures are associated with nonmotor dysfunctions in Parkinson\u2019s disease and atypical parkinsonism: an integrative analysis. Aging Dis 14:204\u2013218. https:\/\/doi.org\/10.14336\/ad.2022.0514","journal-title":"Aging Dis"},{"issue":"Suppl 3","key":"11876_CR7","doi-asserted-by":"publisher","first-page":"iii42","DOI":"10.1136\/jnnp.74.suppl_3.iii42","volume":"74","author":"CJ Mathias","year":"2003","unstructured":"Mathias CJ (2003) Autonomic diseases: management. J Neurol Neurosurg Psychiatry 74(Suppl 3):iii42\u2013iii47. https:\/\/doi.org\/10.1136\/jnnp.74.suppl_3.iii42","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11876_CR8","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 264:1567\u20131582. https:\/\/doi.org\/10.1007\/s00415-016-8375-x","journal-title":"J Neurol"},{"key":"11876_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1586\/14779072.2015.1095090","volume":"13","author":"PK Jones","year":"2015","unstructured":"Jones PK, Shaw BH, Raj SR (2015) Orthostatic hypotension: managing a difficult problem. Expert Rev Cardiovasc Ther 13:1263\u20131276. https:\/\/doi.org\/10.1586\/14779072.2015.1095090","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"11876_CR10","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0115","author":"ASF Ribeiro","year":"2023","unstructured":"Ribeiro ASF, Zerolo BE, L\u00f3pez-Espuela F, S\u00e1nchez R, Fernandes VS (2023) Cardiac system during the aging process. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0115","journal-title":"Aging Dis"},{"key":"11876_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","volume":"8","author":"W Poewe","year":"2022","unstructured":"Poewe W, Stankovic I, Halliday G, Meissner WG, Wenning GK, Pellecchia MT, Seppi K, Palma JA, Kaufmann H (2022) Multiple system atrophy. Nat Rev Dis Primers 8:56. https:\/\/doi.org\/10.1038\/s41572-022-00382-6","journal-title":"Nat Rev Dis Primers"},{"key":"11876_CR12","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.14336\/ad.2021.0214","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li H, Xu X, Luo Y, Deng B, Guo X, Guo Y, Yang W, Wei X, Wang Q (2021) The pathogenesis and treatment of cardiovascular autonomic dysfunction in Parkinson\u2019s disease: what we know and where to go. Aging Dis 12:1675\u20131692. https:\/\/doi.org\/10.14336\/ad.2021.0214","journal-title":"Aging Dis"},{"key":"11876_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3949\/ccjm.77a.09118","volume":"77","author":"JJ Figueroa","year":"2010","unstructured":"Figueroa JJ, Basford JR, Low PA (2010) Preventing and treating orthostatic hypotension: as easy as A, B, C. Clevel Clin J Med 77:298\u2013306. https:\/\/doi.org\/10.3949\/ccjm.77a.09118","journal-title":"Clevel Clin J Med"},{"key":"11876_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s1474-4422(22)00169-7","volume":"21","author":"W Wieling","year":"2022","unstructured":"Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD (2022) Diagnosis and treatment of orthostatic hypotension. Lancet Neurol 21:735\u2013746. https:\/\/doi.org\/10.1016\/s1474-4422(22)00169-7","journal-title":"Lancet Neurol"},{"key":"11876_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0140-6736(92)90932-s","volume":"339","author":"JJ van Lieshout","year":"1992","unstructured":"van Lieshout JJ, ten Harkel AD, Wieling W (1992) Physical manoeuvres for combating orthostatic dizziness in autonomic failure. Lancet (London, England) 339:897\u2013898. https:\/\/doi.org\/10.1016\/0140-6736(92)90932-s","journal-title":"Lancet (London, England)"},{"key":"11876_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11906-013-0362-3","volume":"15","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, Shibao C (2013) Current concepts in orthostatic hypotension management. Curr Hypertens Rep 15:304\u2013312. https:\/\/doi.org\/10.1007\/s11906-013-0362-3","journal-title":"Curr Hypertens Rep"},{"key":"11876_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.amjmed.2020.05.028","volume":"133","author":"EA Loughlin","year":"2020","unstructured":"Loughlin EA, Judge CS, Gorey SE, Costello MM, Murphy RP, Waters RF, Hughes DS, Kenny RA, O\u2019Donnell MJ, Canavan MD (2020) Increased salt intake for orthostatic intolerance syndromes: a systematic review and meta-analysis. Am J Med 133:1471-1478.e1474. https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.028","journal-title":"Am J Med"},{"key":"11876_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s10286-002-0024-z","volume":"12","author":"W Wieling","year":"2002","unstructured":"Wieling W, Van Lieshout JJ, Hainsworth R (2002) Extracellular fluid volume expansion in patients with posturally related syncope. Clin Auton Res 12:242\u2013249. https:\/\/doi.org\/10.1007\/s10286-002-0024-z","journal-title":"Clin Auton Res"},{"key":"11876_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s1474-4422(08)70088-7","volume":"7","author":"PA Low","year":"2008","unstructured":"Low PA, Singer W (2008) Management of neurogenic orthostatic hypotension: an update. Lancet Neurol 7:451\u2013458. https:\/\/doi.org\/10.1016\/s1474-4422(08)70088-7","journal-title":"Lancet Neurol"},{"key":"11876_CR20","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1161\/01.Cir.0000126283.99195.37","volume":"109","author":"J Jordan","year":"2004","unstructured":"Jordan J, Shannon JR, Diedrich A, Black B, Robertson D, Biaggioni I (2004) Water potentiates the pressor effect of ephedra alkaloids. Circulation 109:1823\u20131825. https:\/\/doi.org\/10.1161\/01.Cir.0000126283.99195.37","journal-title":"Circulation"},{"key":"11876_CR21","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/mds.20543","volume":"20","author":"GK Wenning","year":"2005","unstructured":"Wenning GK, Geser F, Poewe W (2005) Therapeutic strategies in multiple system atrophy. Mov Disord 20:S67\u2013S76. https:\/\/doi.org\/10.1002\/mds.20543","journal-title":"Mov Disord"},{"key":"11876_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/hypertensionaha.116.07199","volume":"68","author":"LE Okamoto","year":"2016","unstructured":"Okamoto LE, Diedrich A, Baudenbacher FJ, Harder R, Whitfield JS, Iqbal F, Gamboa A, Shibao CA, Black BK, Raj SR, Robertson D, Biaggioni I (2016) Efficacy of servo-controlled splanchnic venous compression in the treatment of orthostatic hypotension: a randomized comparison with midodrine. Hypertension (Dallas, Tex: 1979) 68:418\u2013426. https:\/\/doi.org\/10.1161\/hypertensionaha.116.07199","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/mdc3.12478","volume":"4","author":"JA Palma","year":"2017","unstructured":"Palma JA, Kaufmann H (2017) Epidemiology, diagnosis, and management of neurogenic orthostatic hypotension. Mov Disord Clin Pract 4:298\u2013308. https:\/\/doi.org\/10.1002\/mdc3.12478","journal-title":"Mov Disord Clin Pract"},{"key":"11876_CR24","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2022.1207","author":"E Rodr\u00edguez-Guti\u00e9rrez","year":"2023","unstructured":"Rodr\u00edguez-Guti\u00e9rrez E, Torres-Costoso A, Pascual-Morena C, Pozuelo-Carrascosa DP, Garrido-Miguel M, Mart\u00ednez-Vizca\u00edno V (2023) Effects of resistance exercise on neuroprotective factors in middle and late life: a systematic review and meta-analysis. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2022.1207","journal-title":"Aging Dis"},{"key":"11876_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/CRD.0b013e31815c8032","volume":"16","author":"MS Medow","year":"2008","unstructured":"Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH (2008) Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 16:4\u201320. https:\/\/doi.org\/10.1097\/CRD.0b013e31815c8032","journal-title":"Cardiol Rev"},{"key":"11876_CR26","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1007\/s00415-011-5946-8","volume":"258","author":"T Ziemssen","year":"2011","unstructured":"Ziemssen T, Fuchs G, Greulich W, Reichmann H, Schwarz M, Herting B (2011) Treatment of dysautonomia in extrapyramidal disorders. J Neurol 258:S339-345. https:\/\/doi.org\/10.1007\/s00415-011-5946-8","journal-title":"J Neurol"},{"key":"11876_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1161\/01.cir.100.3.299","volume":"100","author":"T Sato","year":"1999","unstructured":"Sato T, Kawada T, Shishido T, Sugimachi M, Alexander J Jr, Sunagawa K (1999) Novel therapeutic strategy against central baroreflex failure: a bionic baroreflex system. Circulation 100:299\u2013304. https:\/\/doi.org\/10.1161\/01.cir.100.3.299","journal-title":"Circulation"},{"key":"11876_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0022-510x(02)00126-0","volume":"200","author":"SM Parikh","year":"2002","unstructured":"Parikh SM, Diedrich A, Biaggioni I, Robertson D (2002) The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci 200:1\u201310. https:\/\/doi.org\/10.1016\/s0022-510x(02)00126-0","journal-title":"J Neurol Sci"},{"key":"11876_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1056\/NEJMoa2112809","volume":"386","author":"JW Squair","year":"2022","unstructured":"Squair JW, Berney M, Castro Jimenez M, Hankov N, Demesmaeker R, Amir S, Paley A, Hernandez-Charpak S, Dumont G, Asboth L, Allenbach G, Becce F, Schoettker P, Wuerzner G, Bally JF, Courtine G, Bloch J (2022) Implanted system for orthostatic hypotension in multiple-system atrophy. N Engl J Med 386:1339\u20131344. https:\/\/doi.org\/10.1056\/NEJMoa2112809","journal-title":"N Engl J Med"},{"key":"11876_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1056\/nejm197907123010202","volume":"301","author":"AV Chobanian","year":"1979","unstructured":"Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D (1979) Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 301:68\u201373. https:\/\/doi.org\/10.1056\/nejm197907123010202","journal-title":"N Engl J Med"},{"key":"11876_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1124\/pr.115.012161","volume":"69","author":"I Biaggioni","year":"2017","unstructured":"Biaggioni I (2017) The pharmacology of autonomic failure: from hypotension to hypertension. Pharmacol Rev 69:53\u201362. https:\/\/doi.org\/10.1124\/pr.115.012161","journal-title":"Pharmacol Rev"},{"key":"11876_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1046\/j.1460-9592.2003.t01-1-00155.x","volume":"26","author":"BP Grubb","year":"2003","unstructured":"Grubb BP, Kosinski DJ, Kanjwal Y (2003) Orthostatic hypotension: causes, classification, and treatment. Pacing Clin Electrophysiol PACE 26:892\u2013901. https:\/\/doi.org\/10.1046\/j.1460-9592.2003.t01-1-00155.x","journal-title":"Pacing Clin Electrophysiol PACE"},{"key":"11876_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1212\/wnl.51.1.120","volume":"51","author":"RA Wright","year":"1998","unstructured":"Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51:120\u2013124. https:\/\/doi.org\/10.1212\/wnl.51.1.120","journal-title":"Neurology"},{"key":"11876_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-m","volume":"95","author":"J Jankovic","year":"1993","unstructured":"Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM (1993) Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 95:38\u201348. https:\/\/doi.org\/10.1016\/0002-9343(93)90230-m","journal-title":"Am J Med"},{"key":"11876_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","volume":"38","author":"D McTavish","year":"1989","unstructured":"McTavish D, Goa KL (1989) Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 38:757\u2013777. https:\/\/doi.org\/10.2165\/00003495-198938050-00004","journal-title":"Drugs"},{"issue":"Suppl 1","key":"11876_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10286-007-1002-2","volume":"18","author":"H Kaufmann","year":"2008","unstructured":"Kaufmann H (2008) L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clin Auton Res 18(Suppl 1):19\u201324. https:\/\/doi.org\/10.1007\/s10286-007-1002-2","journal-title":"Clin Auton Res"},{"key":"11876_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/wnl.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ (2014) Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 83:328\u2013335. https:\/\/doi.org\/10.1212\/wnl.0000000000000615","journal-title":"Neurology"},{"key":"11876_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA (2015) Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther 13:875\u2013891. https:\/\/doi.org\/10.1586\/14779072.2015.1057504","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"11876_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G (2015) Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B). Mov Disord 30:646\u2013654. https:\/\/doi.org\/10.1002\/mds.26086","journal-title":"Mov Disord"},{"key":"11876_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082775","author":"L M\u00e9sz\u00e1ros","year":"2020","unstructured":"M\u00e9sz\u00e1ros L, Hoffmann A, Wihan J, Winkler J (2020) Current symptomatic and disease-modifying treatments in multiple system atrophy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21082775","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"11876_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10286-007-1003-1","volume":"18","author":"R Freeman","year":"2008","unstructured":"Freeman R (2008) Current pharmacologic treatment for orthostatic hypotension. Clin Auton Res 18(Suppl 1):14\u201318. https:\/\/doi.org\/10.1007\/s10286-007-1003-1","journal-title":"Clin Auton Res"},{"key":"11876_CR42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00702-005-0379-0","volume":"112","author":"C Colosimo","year":"2005","unstructured":"Colosimo C, Tiple D, Wenning GK (2005) Management of multiple system atrophy: state of the art. J Neural Transm (Vienna, Austria: 1996) 112:1695\u20131704. https:\/\/doi.org\/10.1007\/s00702-005-0379-0","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"key":"11876_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0002-9149(90)90031-u","volume":"65","author":"I Biaggioni","year":"1990","unstructured":"Biaggioni I, Zygmunt D, Haile V, Robertson D (1990) Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol 65:89\u201392. https:\/\/doi.org\/10.1016\/0002-9149(90)90031-u","journal-title":"Am J Cardiol"},{"key":"11876_CR44","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1210\/jcem-68-6-1051","volume":"68","author":"RD Hoeldtke","year":"1989","unstructured":"Hoeldtke RD, Israel BC (1989) Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 68:1051\u20131059. https:\/\/doi.org\/10.1210\/jcem-68-6-1051","journal-title":"J Clin Endocrinol Metab"},{"key":"11876_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7326\/0003-4819-105-2-168","volume":"105","author":"RD Hoeldtke","year":"1986","unstructured":"Hoeldtke RD, Cavanaugh ST, Hughes JD, Polansky M (1986) Treatment of orthostatic hypotension with dihydroergotamine and caffeine. Ann Intern Med 105:168\u2013173. https:\/\/doi.org\/10.7326\/0003-4819-105-2-168","journal-title":"Ann Intern Med"},{"key":"11876_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","volume":"25","author":"J Jordan","year":"2015","unstructured":"Jordan J, Shibao C, Biaggioni I (2015) Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clin Auton Res 25:53\u201359. https:\/\/doi.org\/10.1007\/s10286-015-0271-4","journal-title":"Clin Auton Res"},{"key":"11876_CR47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1172\/jci112611","volume":"78","author":"D Robertson","year":"1986","unstructured":"Robertson D, Goldberg MR, Tung CS, Hollister AS, Robertson RM (1986) Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Investig 78:576\u2013581. https:\/\/doi.org\/10.1172\/jci112611","journal-title":"J Clin Investig"},{"key":"11876_CR48","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1161\/01.cir.101.23.2710","volume":"101","author":"JR Shannon","year":"2000","unstructured":"Shannon JR, Jordan J, Diedrich A, Pohar B, Black BK, Robertson D, Biaggioni I (2000) Sympathetically mediated hypertension in autonomic failure. Circulation 101:2710\u20132715. https:\/\/doi.org\/10.1161\/01.cir.101.23.2710","journal-title":"Circulation"},{"key":"11876_CR49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/j.1552-4604.1994.tb04981.x","volume":"34","author":"I Biaggioni","year":"1994","unstructured":"Biaggioni I, Robertson RM, Robertson D (1994) Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 34:418\u2013423. https:\/\/doi.org\/10.1002\/j.1552-4604.1994.tb04981.x","journal-title":"J Clin Pharmacol"},{"key":"11876_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/hypertensionaha.107.089961","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, Robertson D, Biaggioni I (2007) Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension (Dallas, Tex: 1979) 50:47\u201353. https:\/\/doi.org\/10.1161\/hypertensionaha.107.089961","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR51","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/hypertensionaha.111.184812","volume":"59","author":"LE Okamoto","year":"2012","unstructured":"Okamoto LE, Shibao C, Gamboa A, Choi L, Diedrich A, Raj SR, Black BK, Robertson D, Biaggioni I (2012) Synergistic effect of norepinephrine transporter blockade and \u03b1-2 antagonism on blood pressure in autonomic failure. Hypertension (Dallas, Tex: 1979) 59:650\u2013656. https:\/\/doi.org\/10.1161\/hypertensionaha.111.184812","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR52","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/hypertensionaha.114.04225","volume":"64","author":"CE Ramirez","year":"2014","unstructured":"Ramirez CE, Okamoto LE, Arnold AC, Gamboa A, Diedrich A, Choi L, Raj SR, Robertson D, Biaggioni I, Shibao CA (2014) Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (Dallas, Tex: 1979) 64:1235\u20131240. https:\/\/doi.org\/10.1161\/hypertensionaha.114.04225","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/s0002-9343(98)00193-4","volume":"105","author":"J Jordan","year":"1998","unstructured":"Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D (1998) Contrasting actions of pressor agents in severe autonomic failure. Am J Med 105:116\u2013124. https:\/\/doi.org\/10.1016\/s0002-9343(98)00193-4","journal-title":"Am J Med"},{"key":"11876_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269881114560183","volume":"29","author":"A Camporeale","year":"2015","unstructured":"Camporeale A, Porsdal V, De Bruyckere K, Tanaka Y, Upadhyaya H, Deix C, Deberdt W (2015) Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: an integrated analysis of 15 clinical trials. J Psychopharmacol (Oxford, England) 29:3\u201314. https:\/\/doi.org\/10.1177\/0269881114560183","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"11876_CR55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10286-021-00827-0","volume":"31","author":"H Kaufmann","year":"2021","unstructured":"Kaufmann H, Vickery R, Wang W, Kanodia J, Shibao CA, Norcliffe-Kaufmann L, Haumann B, Biaggioni I (2021) Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clin Auton Res 31:699\u2013711. https:\/\/doi.org\/10.1007\/s10286-021-00827-0","journal-title":"Clin Auton Res"},{"key":"11876_CR56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","volume":"63","author":"W Singer","year":"2006","unstructured":"Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, O\u2019Brien PC, Slezak J, Low PA (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63:513\u2013518. https:\/\/doi.org\/10.1001\/archneur.63.4.noc50340","journal-title":"Arch Neurol"},{"key":"11876_CR57","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1136\/jnnp.74.9.1294","volume":"74","author":"W Singer","year":"2003","unstructured":"Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA (2003) Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 74:1294\u20131298. https:\/\/doi.org\/10.1136\/jnnp.74.9.1294","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11876_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/hypertensionaha.118.11790","volume":"73","author":"LE Okamoto","year":"2019","unstructured":"Okamoto LE, Shibao CA, Gamboa A, Diedrich A, Raj SR, Black BK, Robertson D, Biaggioni I (2019) Synergistic pressor effect of atomoxetine and pyridostigmine in patients with neurogenic orthostatic hypotension. Hypertension (Dallas, Tex: 1979) 73:235\u2013241. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11790","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR59","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI (2018) Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol 72:1294\u20131309. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.079","journal-title":"J Am Coll Cardiol"},{"key":"11876_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/bmj.293.6543.353","volume":"293","author":"CJ Mathias","year":"1986","unstructured":"Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R (1986) The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 293:353\u2013354. https:\/\/doi.org\/10.1136\/bmj.293.6543.353","journal-title":"Br Med J (Clin Res Ed)"},{"key":"11876_CR61","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1212\/wnl.42.3.590","volume":"42","author":"H Kaufmann","year":"1992","unstructured":"Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD (1992) Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology 42:590\u2013593. https:\/\/doi.org\/10.1212\/wnl.42.3.590","journal-title":"Neurology"},{"key":"11876_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10286-003-0052-3","volume":"13","author":"R Sakakibara","year":"2003","unstructured":"Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T (2003) The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 13:106\u2013108. https:\/\/doi.org\/10.1007\/s10286-003-0052-3","journal-title":"Clin Auton Res"},{"key":"11876_CR63","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pharmthera.2011.05.009","volume":"134","author":"C Shibao","year":"2012","unstructured":"Shibao C, Okamoto L, Biaggioni I (2012) Pharmacotherapy of autonomic failure. Pharmacol Ther 134:279\u2013286. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.05.009","journal-title":"Pharmacol Ther"},{"key":"11876_CR64","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/nejm199308263290904","volume":"329","author":"RD Hoeldtke","year":"1993","unstructured":"Hoeldtke RD, Streeten DH (1993) Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 329:611\u2013615. https:\/\/doi.org\/10.1056\/nejm199308263290904","journal-title":"N Engl J Med"},{"key":"11876_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/bf01824009","volume":"5","author":"R Perera","year":"1995","unstructured":"Perera R, Isola L, Kaufmann H (1995) Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 5:211\u2013213. https:\/\/doi.org\/10.1007\/bf01824009","journal-title":"Clin Auton Res"},{"issue":"Suppl 1","key":"11876_CR66","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/j.nephro.2017.01.003","volume":"13","author":"A Joseph","year":"2017","unstructured":"Joseph A, Wanono R, Flamant M, Vidal-Petiot E (2017) Orthostatic hypotension: a review. Nephrol Ther 13(Suppl 1):S55-s67. https:\/\/doi.org\/10.1016\/j.nephro.2017.01.003","journal-title":"Nephrol Ther"},{"key":"11876_CR67","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.parkreldis.2015.05.023","volume":"21","author":"J Suzuki","year":"2015","unstructured":"Suzuki J, Nakamura T, Hirayama M, Mizutani Y, Okada A, Ito M, Watanabe H, Sobue G (2015) Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Parkinsonism Relat Disord 21:917\u2013922. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.05.023","journal-title":"Parkinsonism Relat Disord"},{"key":"11876_CR68","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10286-021-00814-5","volume":"31","author":"JR Gibbon","year":"2021","unstructured":"Gibbon JR, Frith J (2021) The effects of caffeine in adults with neurogenic orthostatic hypotension: a systematic review. Clin Auton Res 31:499\u2013509. https:\/\/doi.org\/10.1007\/s10286-021-00814-5","journal-title":"Clin Auton Res"},{"key":"11876_CR69","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","volume":"358","author":"R Freeman","year":"2008","unstructured":"Freeman R (2008) Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 358:615\u2013624. https:\/\/doi.org\/10.1056\/NEJMcp074189","journal-title":"N Engl J Med"},{"key":"11876_CR70","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.hyp.30.5.1062","volume":"30","author":"J Shannon","year":"1997","unstructured":"Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I (1997) The hypertension of autonomic failure and its treatment. Hypertension (Dallas, Tex: 1979) 30:1062\u20131067. https:\/\/doi.org\/10.1161\/01.hyp.30.5.1062","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR71","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/01.Hyp.0000199982.71858.11","volume":"47","author":"C Shibao","year":"2006","unstructured":"Shibao C, Gamboa A, Abraham R, Raj SR, Diedrich A, Black B, Robertson D, Biaggioni I (2006) Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension (Dallas, Tex: 1979) 47:522\u2013526. https:\/\/doi.org\/10.1161\/01.Hyp.0000199982.71858.11","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR72","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MNH.0b013e328356c52f","volume":"21","author":"AC Arnold","year":"2012","unstructured":"Arnold AC, Biaggioni I (2012) Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens 21:481\u2013485. https:\/\/doi.org\/10.1097\/MNH.0b013e328356c52f","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"11876_CR73","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","volume":"61","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, Biaggioni I (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension (Dallas, Tex: 1979) 61:701\u2013706. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.00377","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR74","doi-asserted-by":"publisher","first-page":"M744","DOI":"10.1093\/gerona\/56.12.m744","volume":"56","author":"LC Vloet","year":"2001","unstructured":"Vloet LC, Mehagnoul-Schipper DJ, Hoefnagels WH, Jansen RW (2001) The influence of low-, normal-, and high-carbohydrate meals on blood pressure in elderly patients with postprandial hypotension. J Gerontol A Biol Sci Med Sci 56:M744-748. https:\/\/doi.org\/10.1093\/gerona\/56.12.m744","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"11876_CR75","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jamda.2014.01.011","volume":"15","author":"LG Trahair","year":"2014","unstructured":"Trahair LG, Horowitz M, Jones KL (2014) Postprandial hypotension: a systematic review. J Am Med Dir Assoc 15:394\u2013409. https:\/\/doi.org\/10.1016\/j.jamda.2014.01.011","journal-title":"J Am Med Dir Assoc"},{"key":"11876_CR76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/jcem.83.2.4534","volume":"83","author":"RD Hoeldtke","year":"1998","unstructured":"Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR (1998) Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 83:339\u2013343. https:\/\/doi.org\/10.1210\/jcem.83.2.4534","journal-title":"J Clin Endocrinol Metab"},{"key":"11876_CR77","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/nejm198508293130905","volume":"313","author":"J Onrot","year":"1985","unstructured":"Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kingaid D, Robertson D (1985) Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 313:549\u2013554. https:\/\/doi.org\/10.1056\/nejm198508293130905","journal-title":"N Engl J Med"},{"key":"11876_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00002826-199502000-00012","volume":"18","author":"R Bordet","year":"1995","unstructured":"Bordet R, Benhadjali J, Dest\u00e9e A, Belabbas A, Libersa C (1995) Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration. Clin Neuropharmacol 18:83\u201389. https:\/\/doi.org\/10.1097\/00002826-199502000-00012","journal-title":"Clin Neuropharmacol"},{"key":"11876_CR79","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00002826-199408000-00010","volume":"17","author":"R Bordet","year":"1994","unstructured":"Bordet R, Benhadjali J, Libersa C, Dest\u00e9e A (1994) Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration. Clin Neuropharmacol 17:380\u2013383","journal-title":"Clin Neuropharmacol"},{"key":"11876_CR80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/hypertensionaha.107.091355","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Gamboa A, Diedrich A, Dossett C, Choi L, Farley G, Biaggioni I (2007) Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension (Dallas, Tex: 1979) 50:54\u201361. https:\/\/doi.org\/10.1161\/hypertensionaha.107.091355","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4111\/kju.2012.53.9.583","volume":"53","author":"WJ Li","year":"2012","unstructured":"Li WJ, Oh SJ (2012) Management of lower urinary tract dysfunction in patients with neurological disorders. Korean J Urol 53:583\u2013592. https:\/\/doi.org\/10.4111\/kju.2012.53.9.583","journal-title":"Korean J Urol"},{"key":"11876_CR82","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1046\/j.1365-2702.1999.00295.x","volume":"8","author":"T Koch","year":"1999","unstructured":"Koch T, Kelly S (1999) Identifying strategies for managing urinary incontinence with women who have multiple sclerosis. J Clin Nurs 8:550\u2013559. https:\/\/doi.org\/10.1046\/j.1365-2702.1999.00295.x","journal-title":"J Clin Nurs"},{"key":"11876_CR83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/nau.20852","volume":"29","author":"JJ Wyndaele","year":"2010","unstructured":"Wyndaele JJ, Kovindha A, Madersbacher H, Radziszewski P, Ruffion A, Schurch B, Castro D, Igawa Y, Sakakibara R, Wein A (2010) Neurologic urinary incontinence. Neurourol Urodyn 29:159\u2013164. https:\/\/doi.org\/10.1002\/nau.20852","journal-title":"Neurourol Urodyn"},{"key":"11876_CR84","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2022.1024","author":"LE Neilson","year":"2023","unstructured":"Neilson LE, Quinn JF, Lim MM (2023) Screening and targeting risk factors for prodromal synucleinopathy: taking steps toward a prescriptive multi-modal framework. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2022.1024","journal-title":"Aging Dis"},{"key":"11876_CR85","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.5152\/tud.2020.20092","volume":"46","author":"M Moussa","year":"2020","unstructured":"Moussa M, Papatsoris A, Chakra MA, Fares Y, Dellis A (2020) Lower urinary tract dysfunction in common neurological diseases. Turk J Urol 46:S70-s78. https:\/\/doi.org\/10.5152\/tud.2020.20092","journal-title":"Turk J Urol"},{"key":"11876_CR86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/nau.20461","volume":"27","author":"AG Papatsoris","year":"2008","unstructured":"Papatsoris AG, Papapetropoulos S, Singer C, Deliveliotis C (2008) Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn 27:22\u201327. https:\/\/doi.org\/10.1002\/nau.20461","journal-title":"Neurourol Urodyn"},{"key":"11876_CR87","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jnnp.2008.159178","volume":"80","author":"CJ Fowler","year":"2009","unstructured":"Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M (2009) A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 80:470\u2013477. https:\/\/doi.org\/10.1136\/jnnp.2008.159178","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 7","key":"11876_CR88","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/brain\/122.7.1213","volume":"122","author":"CJ Fowler","year":"1999","unstructured":"Fowler CJ (1999) Neurological disorders of micturition and their treatment. Brain J Neurol 122(Pt 7):1213\u20131231. https:\/\/doi.org\/10.1093\/brain\/122.7.1213","journal-title":"Brain J Neurol"},{"key":"11876_CR89","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/mds.20867","volume":"21","author":"K Winge","year":"2006","unstructured":"Winge K, Fowler CJ (2006) Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord 21:737\u2013745. https:\/\/doi.org\/10.1002\/mds.20867","journal-title":"Mov Disord"},{"key":"11876_CR90","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C (2011) Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60:742\u2013750. https:\/\/doi.org\/10.1016\/j.eururo.2011.07.002","journal-title":"Eur Urol"},{"key":"11876_CR91","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1100\/tsw.2011.26","volume":"11","author":"CD Cruz","year":"2011","unstructured":"Cruz CD, Cruz F (2011) Spinal cord injury and bladder dysfunction: new ideas about an old problem. Sci World J 11:214\u2013234. https:\/\/doi.org\/10.1100\/tsw.2011.26","journal-title":"Sci World J"},{"key":"11876_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005493.pub3","author":"JB Duthie","year":"2011","unstructured":"Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005493.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"11876_CR93","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jpurol.2011.11.014","volume":"8","author":"R Stein","year":"2012","unstructured":"Stein R, Schr\u00f6der A, Th\u00fcroff JW (2012) Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations. J Pediatr Urol 8:153\u2013161. https:\/\/doi.org\/10.1016\/j.jpurol.2011.11.014","journal-title":"J Pediatr Urol"},{"key":"11876_CR94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.juro.2011.03.023","volume":"186","author":"JS Wiener","year":"2011","unstructured":"Wiener JS, Antonelli J, Shea AM, Curtis LH, Schulman KA, Krupski TL, Scales CD Jr (2011) Bladder augmentation versus urinary diversion in patients with spina bifida in the United States. J Urol 186:161\u2013165. https:\/\/doi.org\/10.1016\/j.juro.2011.03.023","journal-title":"J Urol"},{"key":"11876_CR95","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/s0022-5347(17)35246-1","volume":"151","author":"RO Beck","year":"1994","unstructured":"Beck RO, Betts CD, Fowler CJ (1994) Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 151:1336\u20131341. https:\/\/doi.org\/10.1016\/s0022-5347(17)35246-1","journal-title":"J Urol"},{"key":"11876_CR96","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.5980\/jpnjurol1928.74.10_1844","volume":"74","author":"K Yasuda","year":"1983","unstructured":"Yasuda K, Hattori T, Nakayama T, Kamura K, Yamashiro Y, Murayama N, Hirayama K, Shimazaki J (1983) Management of micturitional disturbance in the patients with Shy\u2013Drager syndrome. Part 2: results of self catheterisation, uropharmacotherapy and transurethral resection of bladder neck. Nihon Hinyokika Gakkai zasshi Jpn J Urol 74:1844\u20131850. https:\/\/doi.org\/10.5980\/jpnjurol1928.74.10_1844","journal-title":"Nihon Hinyokika Gakkai zasshi Jpn J Urol"},{"key":"11876_CR97","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/mds.20815","volume":"21","author":"T Ito","year":"2006","unstructured":"Ito T, Sakakibara R, Yasuda K, Yamamoto T, Uchiyama T, Liu Z, Yamanishi T, Awa Y, Yamamoto K, Hattori T (2006) Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it? Mov Disord 21:816\u2013823. https:\/\/doi.org\/10.1002\/mds.20815","journal-title":"Mov Disord"},{"key":"11876_CR98","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/563294","volume":"2013","author":"J Wors\u00f8e","year":"2013","unstructured":"Wors\u00f8e J, Rasmussen M, Christensen P, Krogh K (2013) Neurostimulation for neurogenic bowel dysfunction. Gastroenterol Res Pract 2013:563294. https:\/\/doi.org\/10.1155\/2013\/563294","journal-title":"Gastroenterol Res Pract"},{"key":"11876_CR99","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0214","author":"SM Chou","year":"2023","unstructured":"Chou SM, Yen YH, Yuan F, Zhang SC, Chong CM (2023) Neuronal senescence in the aged brain. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0214","journal-title":"Aging Dis"},{"key":"11876_CR100","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00210-007-0209-z","volume":"377","author":"N Yoshimura","year":"2008","unstructured":"Yoshimura N, Kaiho Y, Miyazato M, Yunoki T, Tai C, Chancellor MB, Tyagi P (2008) Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol 377:437\u2013448. https:\/\/doi.org\/10.1007\/s00210-007-0209-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"11876_CR101","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11934-004-0012-z","volume":"5","author":"GJ Christ","year":"2004","unstructured":"Christ GJ (2004) Gene therapy treatments for erectile and bladder dysfunction. Curr Urol Rep 5:52\u201360. https:\/\/doi.org\/10.1007\/s11934-004-0012-z","journal-title":"Curr Urol Rep"},{"key":"11876_CR102","doi-asserted-by":"publisher","first-page":"R1699","DOI":"10.1152\/ajpregu.2001.281.5.R1699","volume":"281","author":"GJ Christ","year":"2001","unstructured":"Christ GJ, Day NS, Day M, Santizo C, Zhao W, Sclafani T, Zinman J, Hsieh K, Venkateswarlu K, Valcic M, Melman A (2001) Bladder injection of \u201cnaked\u201d hSlo\/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Am J Physiol Regul Integr Comp Physiol 281:R1699-1709. https:\/\/doi.org\/10.1152\/ajpregu.2001.281.5.R1699","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"11876_CR103","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/mp050093x","volume":"3","author":"P Tyagi","year":"2006","unstructured":"Tyagi P, Banerjee R, Basu S, Yoshimura N, Chancellor M, Huang L (2006) Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates. Mol Pharm 3:398\u2013406. https:\/\/doi.org\/10.1021\/mp050093x","journal-title":"Mol Pharm"},{"key":"11876_CR104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1442-2042.2012.03226.x","volume":"20","author":"N Yoshimura","year":"2013","unstructured":"Yoshimura N, Miyazato M, Sasaki K, Yokoyama H, Oguchi T, Chancellor MB, Funahashi Y (2013) Gene therapy for lower urinary tract dysfunction. Int J Urol 20:56\u201363. https:\/\/doi.org\/10.1111\/j.1442-2042.2012.03226.x","journal-title":"Int J Urol"},{"key":"11876_CR105","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1007\/s00415-016-8212-2","volume":"263","author":"KI Tudor","year":"2016","unstructured":"Tudor KI, Sakakibara R, Panicker JN (2016) Neurogenic lower urinary tract dysfunction: evaluation and management. J Neurol 263:2555\u20132564. https:\/\/doi.org\/10.1007\/s00415-016-8212-2","journal-title":"J Neurol"},{"key":"11876_CR106","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1212\/WNL.0b013e318219fab3","volume":"76","author":"CP Vaughan","year":"2011","unstructured":"Vaughan CP, Juncos JL, Burgio KL, Goode PS, Wolf RA, Johnson TM 2nd (2011) Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology 76:1631\u20131634. https:\/\/doi.org\/10.1212\/WNL.0b013e318219fab3","journal-title":"Neurology"},{"key":"11876_CR107","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/sc.2013.19","volume":"51","author":"H Madersbacher","year":"2013","unstructured":"Madersbacher H, M\u00fcrtz G, St\u00f6hrer M (2013) Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord 51:432\u2013441. https:\/\/doi.org\/10.1038\/sc.2013.19","journal-title":"Spinal Cord"},{"key":"11876_CR108","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1185\/030079902125000570","volume":"18","author":"D Sussman","year":"2002","unstructured":"Sussman D, Garely A (2002) Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET). Curr Med Res Opin 18:177\u2013184. https:\/\/doi.org\/10.1185\/030079902125000570","journal-title":"Curr Med Res Opin"},{"key":"11876_CR109","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/00912700122010528","volume":"41","author":"A Todorova","year":"2001","unstructured":"Todorova A, Vonderheid-Guth B, Dimpfel W (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41:636\u2013644. https:\/\/doi.org\/10.1177\/00912700122010528","journal-title":"J Clin Pharmacol"},{"key":"11876_CR110","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2006.03.016","volume":"51","author":"M St\u00f6hrer","year":"2007","unstructured":"St\u00f6hrer M, M\u00fcrtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ (2007) Propiverine compared to oxybutynin in neurogenic detrusor overactivity\u2014results of a randomized, double-blind, multicenter clinical study. Eur Urol 51:235\u2013242. https:\/\/doi.org\/10.1016\/j.eururo.2006.03.016","journal-title":"Eur Urol"},{"key":"11876_CR111","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.neuroscience.2006.06.044","volume":"142","author":"T Ito","year":"2006","unstructured":"Ito T, Sakakibara R, Nakazawa K, Uchiyama T, Yamamoto T, Liu Z, Shimizu E, Hattori T (2006) Effects of electrical stimulation of the raphe area on the micturition reflex in cats. Neuroscience 142:1273\u20131280. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.06.044","journal-title":"Neuroscience"},{"key":"11876_CR112","first-page":"228","volume":"286","author":"N Yoshimura","year":"1998","unstructured":"Yoshimura N, Mizuta E, Yoshida O, Kuno S (1998) Therapeutic effects of dopamine D1\/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. J Pharmacol Exp Ther 286:228\u2013233","journal-title":"J Pharmacol Exp Ther"},{"key":"11876_CR113","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/s0140-6736(88)90932-4","volume":"2","author":"TJ Christmas","year":"1988","unstructured":"Christmas TJ, Kempster PA, Chapple CR, Frankel JP, Lees AJ, Stern GM, Milroy EJ (1988) Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet (London, England) 2:1451\u20131453. https:\/\/doi.org\/10.1016\/s0140-6736(88)90932-4","journal-title":"Lancet (London, England)"},{"key":"11876_CR114","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000151415","volume":"81","author":"R Sakakibara","year":"2008","unstructured":"Sakakibara R, Ito T, Uchiyama T, Awa Y, Yamaguchi C, Hattori T (2008) Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment. Urol Int 81:335\u2013339. https:\/\/doi.org\/10.1159\/000151415","journal-title":"Urol Int"},{"key":"11876_CR115","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","volume":"57","author":"B Peyronnet","year":"2018","unstructured":"Peyronnet B, Vurture G, Palma JA, Malacarne DR, Feigin A, Sussman RD, Biagioni MC, Palmerola R, Gilbert R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM (2018) Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort. Parkinsonism Relat Disord 57:22\u201326. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.005","journal-title":"Parkinsonism Relat Disord"},{"key":"11876_CR116","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/nau.22645","volume":"34","author":"HC Kuo","year":"2015","unstructured":"Kuo HC, Lee KS, Na Y, Sood R, Nakaji S, Kubota Y, Kuroishi K (2015) Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a \u03b23-adrenoceptor agonist, in patients with overactive bladder in Asia. Neurourol Urodyn 34:685\u2013692. https:\/\/doi.org\/10.1002\/nau.22645","journal-title":"Neurourol Urodyn"},{"key":"11876_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104700","volume":"134","author":"Z Chen","year":"2020","unstructured":"Chen Z, Li G, Liu J (2020) Autonomic dysfunction in Parkinson\u2019s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 134:104700. https:\/\/doi.org\/10.1016\/j.nbd.2019.104700","journal-title":"Neurobiol Dis"},{"issue":"Suppl 2","key":"11876_CR118","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/sj.bjp.0706619","volume":"147","author":"MC Michel","year":"2006","unstructured":"Michel MC, Vrydag W (2006) Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147(Suppl 2):S88-119. https:\/\/doi.org\/10.1038\/sj.bjp.0706619","journal-title":"Br J Pharmacol"},{"key":"11876_CR119","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0165-1838(99)00105-8","volume":"79","author":"R Sakakibara","year":"2000","unstructured":"Sakakibara R, Hattori T, Uchiyama T, Suenaga T, Takahashi H, Yamanishi T, Egoshi K, Sekita N (2000) Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 79:191\u2013195. https:\/\/doi.org\/10.1016\/s0165-1838(99)00105-8","journal-title":"J Auton Nerv Syst"},{"issue":"Suppl 2","key":"11876_CR120","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/sj.bjp.0706604","volume":"147","author":"WC de Groat","year":"2006","unstructured":"de Groat WC (2006) Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 147(Suppl 2):S25-40. https:\/\/doi.org\/10.1038\/sj.bjp.0706604","journal-title":"Br J Pharmacol"},{"key":"11876_CR121","doi-asserted-by":"publisher","DOI":"10.4081\/aiua.2020.4.371","author":"M Moussa","year":"2020","unstructured":"Moussa M, Papatsoris AG, Abou Chakra M, Dabboucy B, Fares Y (2020) Erectile dysfunction in common neurological conditions: a narrative review. Archivio italiano di urologia, andrologia organo ufficiale di Societa italiana [di] ecografia urologica e nefrologica. https:\/\/doi.org\/10.4081\/aiua.2020.4.371","journal-title":"Archivio italiano di urologia, andrologia organo ufficiale di Societa italiana [di] ecografia urologica e nefrologica."},{"key":"11876_CR122","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510x(95)00355-6","volume":"137","author":"AJ McDougall","year":"1996","unstructured":"McDougall AJ, McLeod JG (1996) Autonomic neuropathy, I. Clinical features, investigation, pathophysiology, and treatment. J Neurol Sci 137:79\u201388. https:\/\/doi.org\/10.1016\/0022-510x(95)00355-6","journal-title":"J Neurol Sci"},{"key":"11876_CR123","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5694\/mja2.50167","volume":"210","author":"CG McMahon","year":"2019","unstructured":"McMahon CG (2019) Current diagnosis and management of erectile dysfunction. Med J Aust 210:469\u2013476. https:\/\/doi.org\/10.5694\/mja2.50167","journal-title":"Med J Aust"},{"key":"11876_CR124","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3978\/j.issn.2223-4683.2016.01.07","volume":"5","author":"AN Shridharani","year":"2016","unstructured":"Shridharani AN, Brant WO (2016) The treatment of erectile dysfunction in patients with neurogenic disease. Transl Androl Urol 5:88\u2013101. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2016.01.07","journal-title":"Transl Androl Urol"},{"key":"11876_CR125","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/157488911794079082","volume":"6","author":"RS Calabr\u00f2","year":"2011","unstructured":"Calabr\u00f2 RS, Polimeni G, Bramanti P (2011) Current and future therapies of erectile dysfunction in neurological disorders. Recent Pat CNS Drug Discov 6:48\u201364. https:\/\/doi.org\/10.2174\/157488911794079082","journal-title":"Recent Pat CNS Drug Discov"},{"key":"11876_CR126","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0022-5347(05)00344-7","volume":"175","author":"DH Zermann","year":"2006","unstructured":"Zermann DH, Kutzenberger J, Sauerwein D, Schubert J, Loeffler U (2006) Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol 175:1041\u20131044. https:\/\/doi.org\/10.1016\/s0022-5347(05)00344-7. (discussion 1044)","journal-title":"J Urol"},{"key":"11876_CR127","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.ju.0000063375.12512.6e","volume":"170","author":"A Melman","year":"2003","unstructured":"Melman A, Zhao W, Davies KP, Bakal R, Christ GJ (2003) The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 170:285\u2013290. https:\/\/doi.org\/10.1097\/01.ju.0000063375.12512.6e","journal-title":"J Urol"},{"key":"11876_CR128","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000066725","volume":"76","author":"JR Vignes","year":"2001","unstructured":"Vignes JR, Liguoro D, Sesay M, Barat M, Guerin J (2001) Dorsal rhizotomy with anterior sacral root stimulation for neurogenic bladder. Stereotact Funct Neurosurg 76:243\u2013245. https:\/\/doi.org\/10.1159\/000066725","journal-title":"Stereotact Funct Neurosurg"},{"key":"11876_CR129","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1745-7262.2008.00389.x","volume":"10","author":"CS Lin","year":"2008","unstructured":"Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF (2008) Recent advances in andrology-related stem cell research. Asian J Androl 10:171\u2013175. https:\/\/doi.org\/10.1111\/j.1745-7262.2008.00389.x","journal-title":"Asian J Androl"},{"key":"11876_CR130","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0208","author":"X Jiang","year":"2023","unstructured":"Jiang X, Li W, Ge L, Lu M (2023) Mesenchymal stem cell senescence during aging: from mechanisms to rejuvenation strategies. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0208","journal-title":"Aging Dis"},{"key":"11876_CR131","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","volume":"71","author":"IF Hussain","year":"2001","unstructured":"Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ (2001) Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson\u2019s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 71:371\u2013374. https:\/\/doi.org\/10.1136\/jnnp.71.3.371","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11876_CR132","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1743-6109.2009.01627.x","volume":"7","author":"I Eardley","year":"2010","unstructured":"Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K, Munarriz R, Lee SW (2010) Pharmacotherapy for erectile dysfunction. J Sex Med 7:524\u2013540. https:\/\/doi.org\/10.1111\/j.1743-6109.2009.01627.x","journal-title":"J Sex Med"},{"key":"11876_CR133","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/924605","volume":"2011","author":"R Sakakibara","year":"2011","unstructured":"Sakakibara R, Kishi M, Ogawa E, Tateno F, Uchiyama T, Yamamoto T, Yamanishi T (2011) Bladder, bowel, and sexual dysfunction in Parkinson\u2019s disease. Parkinson\u2019s Dis 2011:924605. https:\/\/doi.org\/10.4061\/2011\/924605","journal-title":"Parkinson's Dis"},{"key":"11876_CR134","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1464-410X.2006.06253.x","volume":"98","author":"KM Maclennan","year":"2006","unstructured":"Maclennan KM, Boshier A, Wilton LV, Shakir SA (2006) Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction. BJU Int 98:125\u2013131. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06253.x","journal-title":"BJU Int"},{"key":"11876_CR135","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.peptides.2005.01.029","volume":"27","author":"ME Hadley","year":"2006","unstructured":"Hadley ME, Dorr RT (2006) Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27:921\u2013930. https:\/\/doi.org\/10.1016\/j.peptides.2005.01.029","journal-title":"Peptides"},{"key":"11876_CR136","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.juro.2007.10.063","volume":"179","author":"MR Safarinejad","year":"2008","unstructured":"Safarinejad MR, Hosseini SY (2008) Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. J Urol 179:1066\u20131071. https:\/\/doi.org\/10.1016\/j.juro.2007.10.063","journal-title":"J Urol"},{"key":"11876_CR137","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/bf02577009","volume":"11","author":"I Goldstein","year":"1988","unstructured":"Goldstein I, Payton T, Padma-Nathan H (1988) Therapeutic roles of intracavernosal papaverine. Cardiovasc Intervent Radiol 11:237\u2013239. https:\/\/doi.org\/10.1007\/bf02577009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11876_CR138","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1464-410X.2008.07764.x","volume":"102","author":"WW Dinsmore","year":"2008","unstructured":"Dinsmore WW, Wyllie MG (2008) Vasoactive intestinal polypeptide\/phentolamine for intracavernosal injection in erectile dysfunction. BJU Int 102:933\u2013937. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07764.x","journal-title":"BJU Int"},{"key":"11876_CR139","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/sj.ijir.3901313","volume":"17","author":"R Seyam","year":"2005","unstructured":"Seyam R, Mohamed K, Akhras AA, Rashwan H (2005) A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1. Int J Impot Res 17:346\u2013353. https:\/\/doi.org\/10.1038\/sj.ijir.3901313","journal-title":"Int J Impot Res"},{"key":"11876_CR140","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000475059","volume":"28","author":"H van Ahlen","year":"1995","unstructured":"van Ahlen H, Piechota HJ, Kias HJ, Brennemann W, Klingm\u00fcller D (1995) Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone. Eur Urol 28:246\u2013250. https:\/\/doi.org\/10.1159\/000475059","journal-title":"Eur Urol"},{"key":"11876_CR141","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00042307-200011000-00017","volume":"10","author":"F Giuliano","year":"2000","unstructured":"Giuliano F, Rampin O (2000) Central control of erection and its pharmacological modification. Curr Opin Urol 10:629\u2013633. https:\/\/doi.org\/10.1097\/00042307-200011000-00017","journal-title":"Curr Opin Urol"},{"key":"11876_CR142","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.apmr.2017.09.001","volume":"99","author":"M Alexander","year":"2018","unstructured":"Alexander M, Bashir K, Alexander C, Marson L, Rosen R (2018) Randomized trial of clitoral vacuum suction versus vibratory stimulation in neurogenic female orgasmic dysfunction. Arch Phys Med Rehabil 99:299\u2013305. https:\/\/doi.org\/10.1016\/j.apmr.2017.09.001","journal-title":"Arch Phys Med Rehabil"},{"key":"11876_CR143","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1743-6109.2008.00812.x","volume":"5","author":"G Lombardi","year":"2008","unstructured":"Lombardi G, Mondaini N, Macchiarella A, Cilotti A, Del Popolo G (2008) Clinical female sexual outcome after sacral neuromodulation implant for lower urinary tract symptom (LUTS). J Sex Med 5:1411\u20131417. https:\/\/doi.org\/10.1111\/j.1743-6109.2008.00812.x","journal-title":"J Sex Med"},{"key":"11876_CR144","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2165\/00003495-200363140-00002","volume":"63","author":"JL Fourcroy","year":"2003","unstructured":"Fourcroy JL (2003) Female sexual dysfunction: potential for pharmacotherapy. Drugs 63:1445\u20131457. https:\/\/doi.org\/10.2165\/00003495-200363140-00002","journal-title":"Drugs"},{"key":"11876_CR145","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0226-1","author":"X Xiao","year":"2023","unstructured":"Xiao X, Jiang H, Wei H, Zhou Y, Ji X, Zhou C (2023) Endothelial senescence in neurological diseases. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0226-1","journal-title":"Aging Dis"},{"key":"11876_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13030226","author":"SD Mitchell","year":"2021","unstructured":"Mitchell SD, Sidiropoulos C (2021) Therapeutic applications of botulinum neurotoxin for autonomic symptoms in Parkinson\u2019s disease: an updated review. Toxins. https:\/\/doi.org\/10.3390\/toxins13030226","journal-title":"Toxins"},{"key":"11876_CR147","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ene.12880","volume":"23","author":"R Ueha","year":"2016","unstructured":"Ueha R, Nito T, Sakamoto T, Yamauchi A, Tsunoda K, Yamasoba T (2016) Post-operative swallowing in multiple system atrophy. Eur J Neurol 23:393\u2013400. https:\/\/doi.org\/10.1111\/ene.12880","journal-title":"Eur J Neurol"},{"key":"11876_CR148","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s13311-020-00890-x","volume":"17","author":"MR Burns","year":"2020","unstructured":"Burns MR, McFarland NR (2020) Current management and emerging therapies in multiple system atrophy. Neurother J Am Soc Exp NeuroTher 17:1582\u20131602. https:\/\/doi.org\/10.1007\/s13311-020-00890-x","journal-title":"Neurother J Am Soc Exp NeuroTher"},{"key":"11876_CR149","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0309","author":"Z Xie","year":"2023","unstructured":"Xie Z, Zhang M, Luo Y, Jin D, Guo X, Yang W, Zheng J, Zhang H, Zhang L, Deng C, Zheng W, Tan EK, Jin K, Zhu S, Wang Q (2023) Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK\/SOD2 pathway. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0309","journal-title":"Aging Dis"},{"key":"11876_CR150","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s10072-021-05041-4","volume":"42","author":"R Sakakibara","year":"2021","unstructured":"Sakakibara R (2021) Gastrointestinal dysfunction in movement disorders. Neurol Sci 42:1355\u20131365. https:\/\/doi.org\/10.1007\/s10072-021-05041-4","journal-title":"Neurol Sci"},{"key":"11876_CR151","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10286-020-00745-7","volume":"31","author":"KA Chung","year":"2021","unstructured":"Chung KA, Pfeiffer RF (2021) Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 31:77\u201399. https:\/\/doi.org\/10.1007\/s10286-020-00745-7","journal-title":"Clin Auton Res"},{"key":"11876_CR152","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/mds.21752","volume":"22","author":"A-G Postma","year":"2007","unstructured":"Postma A-G, Heesters M, van Laar T (2007) Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism. Mov Disord 22:2430\u20132435. https:\/\/doi.org\/10.1002\/mds.21752","journal-title":"Mov Disord"},{"key":"11876_CR153","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s11894-007-0032-1","volume":"9","author":"J Maranki","year":"2007","unstructured":"Maranki J, Parkman HP (2007) Gastric electric stimulation for the treatment of gastroparesis. Curr Gastroenterol Rep 9:286\u2013294. https:\/\/doi.org\/10.1007\/s11894-007-0032-1","journal-title":"Curr Gastroenterol Rep"},{"key":"11876_CR154","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1365-2168.1999.01047.x","volume":"86","author":"RF McKee","year":"1999","unstructured":"McKee RF, McEnroe L, Anderson JH, Finlay IG (1999) Identification of patients likely to benefit from biofeedback for outlet obstruction constipation. Br J Surg 86:355\u2013359. https:\/\/doi.org\/10.1046\/j.1365-2168.1999.01047.x","journal-title":"Br J Surg"},{"key":"11876_CR155","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/mds.1211","volume":"16","author":"TE Eichhorn","year":"2001","unstructured":"Eichhorn TE, Oertel WH (2001) Macrogol 3350\/electrolyte improves constipation in Parkinson\u2019s disease and multiple system atrophy. Mov Disord 16:1176\u20131177. https:\/\/doi.org\/10.1002\/mds.1211","journal-title":"Mov Disord"},{"key":"11876_CR156","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0016-5085(80)90578-8","volume":"78","author":"JR Malagelada","year":"1980","unstructured":"Malagelada JR, Rees WD, Mazzotta LJ, Go VL (1980) Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology 78:286\u2013293","journal-title":"Gastroenterology"},{"key":"11876_CR157","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1056\/NEJMoa1010863","volume":"365","author":"AJ Lembo","year":"2011","unstructured":"Lembo AJ, Schneier HA, Shiff SJ, Kurtz CB, MacDougall JE, Jia XD, Shao JZ, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Eng P, Fox SM, Johnston JM (2011) Two randomized trials of linaclotide for chronic constipation. N Engl J Med 365:527\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1010863","journal-title":"N Engl J Med"},{"key":"11876_CR158","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ajg.2016.611","volume":"112","author":"PB Miner Jr","year":"2017","unstructured":"Miner PB Jr, Koltun WD, Wiener GJ, De La Portilla M, Prieto B, Shailubhai K, Layton MB, Barrow L, Magnus L, Griffin PH (2017) A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation. Am J Gastroenterol 112:613\u2013621. https:\/\/doi.org\/10.1038\/ajg.2016.611","journal-title":"Am J Gastroenterol"},{"key":"11876_CR159","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/mds.10276","volume":"17","author":"HC Hyson","year":"2002","unstructured":"Hyson HC, Johnson AM, Jog MS (2002) Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 17:1318\u20131320. https:\/\/doi.org\/10.1002\/mds.10276","journal-title":"Mov Disord"},{"key":"11876_CR160","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.purol.2013.07.004","volume":"23","author":"A Ohannessian","year":"2013","unstructured":"Ohannessian A, Kabor\u00e9 FA, Agostini A, Lenne Aurier K, Witjas T, Azulay JP, Karsenty G (2013) Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson\u2019s syndromes. Progres en urologie journal de l\u2019Association francaise d\u2019urologie et de la Societe francaise d\u2019urologie 23:936\u2013939. https:\/\/doi.org\/10.1016\/j.purol.2013.07.004","journal-title":"Progres en urologie journal de l'Association francaise d'urologie et de la Societe francaise d'urologie"},{"key":"11876_CR161","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/hypertensionaha.110.154898","volume":"56","author":"C Shibao","year":"2010","unstructured":"Shibao C, Okamoto LE, Gamboa A, Yu C, Diedrich A, Raj SR, Robertson D, Biaggioni I (2010) Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (Dallas, Tex: 1979) 56:847\u2013851. https:\/\/doi.org\/10.1161\/hypertensionaha.110.154898","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR162","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3988\/jcn.2022.0018","volume":"19","author":"YJ Jung","year":"2023","unstructured":"Jung YJ, Kim A, Okamoto LE, Hong WH (2023) Effects of atomoxetine for the treatment of neurogenic orthostatic hypotension in patients with alpha-synucleinopathies: a systematic review of randomized controlled trials and a focus-group discussion. J Clin Neurol (Seoul, Korea) 19:165\u2013173. https:\/\/doi.org\/10.3988\/jcn.2022.0018","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"11876_CR163","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.0954-6820.1978.tb14829.x","volume":"203","author":"M Oka","year":"1978","unstructured":"Oka M, M\u00e4kel\u00e4 M (1978) Minoxidil in severe hypertension. Acta Med Scand 203:43\u201347. https:\/\/doi.org\/10.1111\/j.0954-6820.1978.tb14829.x","journal-title":"Acta Med Scand"},{"key":"11876_CR164","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/hypertensionaha.107.105171","volume":"51","author":"A Gamboa","year":"2008","unstructured":"Gamboa A, Shibao C, Diedrich A, Paranjape SY, Farley G, Christman B, Raj SR, Robertson D, Biaggioni I (2008) Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension (Dallas, Tex: 1979) 51:1531\u20131536. https:\/\/doi.org\/10.1161\/hypertensionaha.107.105171","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"11876_CR165","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1681\/asn.V10135","volume":"10","author":"J Jordan","year":"1999","unstructured":"Jordan J, Shannon JR, Pohar B, Paranjape SY, Robertson D, Robertson RM, Biaggioni I (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10:35\u201342. https:\/\/doi.org\/10.1681\/asn.V10135","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"11876_CR166","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/00003495-199000392-00013","volume":"39","author":"P Gueret","year":"1990","unstructured":"Gueret P, Artigou JY, Benichou M, Berland J, Fressinaud P, Grollier G, Nguyen CD (1990) Comparative efficacy and safety of enalapril and sustained-release nifedipine in patients with mild to moderate hypertension. The Enalapril vs Nifedipine French Study Group. Drugs 39(Suppl 2):67\u201372. https:\/\/doi.org\/10.2165\/00003495-199000392-00013","journal-title":"Drugs"},{"key":"11876_CR167","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00415-012-6660-x","volume":"260","author":"T Fukushima","year":"2013","unstructured":"Fukushima T, Asahina M, Fujinuma Y, Yamanaka Y, Katagiri A, Mori M, Kuwabara S (2013) Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. J Neurol 260:475\u2013483. https:\/\/doi.org\/10.1007\/s00415-012-6660-x","journal-title":"J Neurol"},{"key":"11876_CR168","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1464-410X.2007.06980.x","volume":"100","author":"WD Steers","year":"2007","unstructured":"Steers WD, Herschorn S, Kreder KJ, Moore K, Strohbehn K, Yalcin I, Bump RC (2007) Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int 100:337\u2013345. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.06980.x","journal-title":"BJU Int"},{"key":"11876_CR169","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1464-410x.1999.00935.x","volume":"83","author":"WW Dinsmore","year":"1999","unstructured":"Dinsmore WW, Gingell C, Hackett G, Kell P, Savage D, Oakes R, Frentz GD (1999) Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study. BJU Int 83:274\u2013279. https:\/\/doi.org\/10.1046\/j.1464-410x.1999.00935.x","journal-title":"BJU Int"},{"key":"11876_CR170","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/s0022-5347(01)63942-9","volume":"159","author":"E Ernst","year":"1998","unstructured":"Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159:433\u2013436. https:\/\/doi.org\/10.1016\/s0022-5347(01)63942-9","journal-title":"J Urol"},{"key":"11876_CR171","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/s2213-8587(19)30189-5","volume":"7","author":"RM Islam","year":"2019","unstructured":"Islam RM, Bell RJ, Green S, Page MJ, Davis SR (2019) Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol 7:754\u2013766. https:\/\/doi.org\/10.1016\/s2213-8587(19)30189-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"11876_CR172","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1097\/01.ju.0000090966.74607.34","volume":"170","author":"JR Berman","year":"2003","unstructured":"Berman JR, Berman LA, Toler SM, Gill J, Haughie S (2003) Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol 170:2333\u20132338. https:\/\/doi.org\/10.1097\/01.ju.0000090966.74607.34","journal-title":"J Urol"},{"key":"11876_CR173","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/01674820500237973","volume":"27","author":"JR Heiman","year":"2006","unstructured":"Heiman JR, Gittelman M, Costabile R, Guay A, Friedman A, Heard-Davison A, Peterson C, Dietrich J, Stephens D (2006) Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: in-clinic evaluation of safety and efficacy. J Psychosom Obstet Gynaecol 27:31\u201341. https:\/\/doi.org\/10.1080\/01674820500237973","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"11876_CR174","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/whe-2016-0018","volume":"12","author":"AH Clayton","year":"2016","unstructured":"Clayton AH, Althof SE, Kingsberg S, DeRogatis LR, Kroll R, Goldstein I, Kaminetsky J, Spana C, Lucas J, Jordan R, Portman DJ (2016) Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond Engl) 12:325\u2013337. https:\/\/doi.org\/10.2217\/whe-2016-0018","journal-title":"Womens Health (Lond Engl)"},{"key":"11876_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-023-00413-x","volume":"23","author":"DR Junqueira","year":"2023","unstructured":"Junqueira DR, Bennett D, Huh SY, Fahrbach K, Neupane B, Betts M (2023) Risk of adverse events associated with domperidone and metoclopramide in gastroparesis: systematic review and meta-analysis. Drugs R&D 23:1\u201320. https:\/\/doi.org\/10.1007\/s40268-023-00413-x","journal-title":"Drugs R&D"},{"key":"11876_CR176","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00535-018-01545-7","volume":"54","author":"K Kasugai","year":"2019","unstructured":"Kasugai K, Iwai H, Kuboyama N, Yoshikawa A, Fukudo S (2019) Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study. J Gastroenterol 54:530\u2013540. https:\/\/doi.org\/10.1007\/s00535-018-01545-7","journal-title":"J Gastroenterol"},{"key":"11876_CR177","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/mdc3.12577","volume":"5","author":"ME Freitas","year":"2018","unstructured":"Freitas ME, Alqaraawi A, Lang AE, Liu LWC (2018) Linaclotide and prucalopride for management of constipation in patients with parkinsonism. Mov Disord Clin Pract 5:218\u2013220. https:\/\/doi.org\/10.1002\/mdc3.12577","journal-title":"Mov Disord Clin Pract"},{"key":"11876_CR178","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","volume":"78","author":"WG Ondo","year":"2012","unstructured":"Ondo WG, Kenney C, Sullivan K, Davidson A, Hunter C, Jahan I, McCombs A, Miller A, Zesiewicz TA (2012) Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology 78:1650\u20131654. https:\/\/doi.org\/10.1212\/WNL.0b013e3182574f28","journal-title":"Neurology"},{"key":"11876_CR179","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s2468-1253(18)30123-7","volume":"3","author":"A Nakajima","year":"2018","unstructured":"Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M (2018) Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol 3:537\u2013547. https:\/\/doi.org\/10.1016\/s2468-1253(18)30123-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11876_CR180","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.cgh.2015.04.184","volume":"13","author":"A Acosta","year":"2015","unstructured":"Acosta A, Camilleri M, Kolar G, Iturrino J, Szarka LA, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR, Spence SC, Gottesdiener K, Bouras EP, Vazquez-Roque MI (2015) Relamorelin relieves constipation and accelerates colonic transit in a phase 2, placebo-controlled, randomized trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 13:2312-2319.e2311. https:\/\/doi.org\/10.1016\/j.cgh.2015.04.184","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"11876_CR181","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11910-021-01104-3","volume":"21","author":"SH Isaacson","year":"2021","unstructured":"Isaacson SH, Dashtipour K, Mehdirad AA, Peltier AC (2021) Management strategies for comorbid supine hypertension in patients with neurogenic orthostatic hypotension. Curr Neurol Neurosci Rep 21:18. https:\/\/doi.org\/10.1007\/s11910-021-01104-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"11876_CR182","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/s0002-9343(99)80246-0","volume":"99","author":"FM Fouad-Tarazi","year":"1995","unstructured":"Fouad-Tarazi FM, Okabe M, Goren H (1995) Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 99:604\u2013610. https:\/\/doi.org\/10.1016\/s0002-9343(99)80246-0","journal-title":"Am J Med"},{"key":"11876_CR183","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/s0140-6736(78)90610-4","volume":"1","author":"B Davies","year":"1978","unstructured":"Davies B, Bannister R, Sever P (1978) Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Limitations and hazards. Lancet (London, England) 1:172\u2013175. https:\/\/doi.org\/10.1016\/s0140-6736(78)90610-4","journal-title":"Lancet (London, England)"},{"key":"11876_CR184","first-page":"164","volume":"18","author":"JR Hopson","year":"1993","unstructured":"Hopson JR, Rea RF, Kienzle MG (1993) Alterations in reflex function contributing to syncope: orthostatic hypotension, carotid sinus hypersensitivity and drug-induced dysfunction. Herz 18:164\u2013174","journal-title":"Herz"},{"key":"11876_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2020.102721","volume":"229","author":"JW Park","year":"2020","unstructured":"Park JW, Okamoto LE, Shibao CA, Biaggioni I (2020) Pharmacologic treatment of orthostatic hypotension. Auton Neurosci Basic Clin 229:102721. https:\/\/doi.org\/10.1016\/j.autneu.2020.102721","journal-title":"Auton Neurosci Basic Clin"},{"key":"11876_CR186","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0163-7258(01)00156-5","volume":"91","author":"SW Tam","year":"2001","unstructured":"Tam SW, Worcel M, Wyllie M (2001) Yohimbine: a clinical review. Pharmacol Ther 91:215\u2013243. https:\/\/doi.org\/10.1016\/s0163-7258(01)00156-5","journal-title":"Pharmacol Ther"},{"key":"11876_CR187","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/ajh\/hpaa131","volume":"34","author":"JF Idiaquez","year":"2021","unstructured":"Idiaquez JF, Idiaquez J, Casar JC, Biaggioni I (2021) Neurogenic orthostatic hypotension. Lessons from synucleinopathies. Am J Hypertens 34:125\u2013133. https:\/\/doi.org\/10.1093\/ajh\/hpaa131","journal-title":"Am J Hypertens"},{"key":"11876_CR188","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11906-022-01168-7","volume":"24","author":"JW Park","year":"2022","unstructured":"Park JW, Okamoto LE, Biaggioni I (2022) Advances in the pathophysiology and management of supine hypertension in patients with neurogenic orthostatic hypotension. Curr Hypertens Rep 24:45\u201354. https:\/\/doi.org\/10.1007\/s11906-022-01168-7","journal-title":"Curr Hypertens Rep"},{"key":"11876_CR189","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/nau.24272","volume":"39","author":"E Rovner","year":"2020","unstructured":"Rovner E, Chai TC, Jacobs S, Christ G, Andersson KE, Efros M, Nitti V, Davies K, McCullough AR, Melman A (2020) Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn 39:744\u2013753. https:\/\/doi.org\/10.1002\/nau.24272","journal-title":"Neurourol Urodyn"},{"key":"11876_CR190","first-page":"143","volume":"9","author":"A Melman","year":"2007","unstructured":"Melman A, Bar-Chama N, McCullough A, Davies K, Christ G (2007) Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial. Israel Med Assoc J IMAJ 9:143\u2013146","journal-title":"Israel Med Assoc J IMAJ"},{"key":"11876_CR191","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1159\/000517364","volume":"105","author":"S Al Demour","year":"2021","unstructured":"Al Demour S, Adwan S, Jafar H, Rahmeh R, Alhawari H, Awidi A (2021) Safety and efficacy of 2 intracavernous injections of allogeneic Wharton\u2019s jelly-derived mesenchymal stem cells in diabetic patients with erectile dysfunction: phase 1\/2 clinical trial. Urol Int 105:935\u2013943. https:\/\/doi.org\/10.1159\/000517364","journal-title":"Urol Int"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11876-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:05:15Z","timestamp":1697274315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11876-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":191,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["11876"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11876-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}